Infectious Diseases Society of America and Gain-of-Function Experiments with Pathogens Having Pandemic Potential

Journal of Infectious Diseases

Volumn 213, Issue 9, 2016, Pages 1359-1361

  Frank, Gregory M ^a   Adalja, Amesh ^c   Barbour, Alan ^d   Casadevall, Arturo ^g   Dormitzer, Philip R ⁱ   Duchin, Jeff ^l,m   Hayden, Frederick G ^b   Hirsch, Martin S ^j   Hynes, Noreen A ^h   Lipsitch, Marc ^k   Pavia, Andrew T ⁿ   Relman, David A ^e,f  

^a Infectious Diseases Society of America Emerging Infections Network   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY   (United States)

^g Johns Hopkins Bloomberg School of Public Health ^*  (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ NVS Influenza Vaccines   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l Public Health of Seattle and King County   (United States)

^m UNIVERSITY OF WASHINGTON   (United States)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

gain of function; health policy; influenza; potential pandemic pathogens; science policy

Indexed keywords

DISEASE TRANSMISSION; EPIDEMIC; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; NONHUMAN; NOTE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; RISK BENEFIT ANALYSIS; VACCINE PRODUCTION; ANIMAL; METHODOLOGY; PANDEMICS; RNA VIRUS INFECTION; STANDARDS;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; PANDEMICS; RESEARCH DESIGN; RNA VIRUS INFECTIONS;

EID: 84971643932     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv474     Document Type: Note

References (11)

1. Casadevall A, Imperiale MJ. Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: A call for a science-based discussion. MBio 2014; 5: e01730-14.
2. Duprex WP, Fouchier RA, Imperiale MJ, Lipsitch MRelman DA. Gain-of-function experiments: time for a real debate. Nat Rev Microbiol 2015; 13:58-64.
3. Lipsitch M, Inglesby TV. Moratorium on research intended to create novel potential pandemic pathogens. MBio 2014; 5:e02366-14.
4. Wain-Hobson S. the irrationality of GOF avian influenza virus research. Front Public Health 2014; 2:77.
5. Kilianski A, Nuzzo JB, Modjarrad K. Gainof-function research and the relevance to clinical practice. J Infect Dis 2016; 213:1364-9.
6. Burnet FM. Growth of influenza virus in the allantoic cavity of the chick embryo. Aust J Exp Biol Med Sci 1941; 19:291-5.
7. Members of the Commission on Influenza, Board for The Investigation and Control of Influenza and Other Empiric Diseases in the Army, Preventive Medicine Service, Office of the Surgeon General, United States Army. A clinical evaluation of vaccination against influenza: Preliminary report. JAMA 1944; 124:982-5.
8. Relman DA. the increasingly compelling moral responsibilities of life scientists. Hastings Cent Rep 2013; 43:34-5.
9. Casadevall A, Howard D, Imperiale MJ. An epistemological perspective on the value of gain-offunction experiments involving pathogens with pandemic potential. MBio 2014; 5:e01875-14.
10. Pfeiffer JK. Is the debate and "pause" on experiments that alter pathogens with pandemic potential influencing future plans of graduate students and postdoctoral fellows? MBio 2015; 6: e02525-14.
11. Langlois RA, Albrecht RA, Kimble B, et al. Micro-RNA-based strategy to mitigate the risk of gain-offunction influenza studies. Nat Biotechnol 2013; 31:844-7.